Pricing Log in Create free account

MannKind Corporation (MNKD) vs Vor Biopharma Inc. (VOR)

MannKind Corporation and Vor Biopharma Inc. are both Biotechnology companies. Vor Biopharma Inc. is the larger, with a market value of $1.1B against $1.0B — 1.1× the size. Vor Biopharma Inc. has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 12 metrics below, MannKind Corporation leads on 7 and Vor Biopharma Inc. on 5.

Valuation

Metric MNKD VOR Biotechnology median
P/E n/m n/m 8.50
P/S 2.39 n/m 9.71
P/B n/m 6.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 39.75 n/m 0.64
EV/Sales 3.18 n/m 9.21
Earnings yield (4.28%) (2,102.61%) (33.15%)
Free cash flow yield (1.93%) (7.76%) (25.50%)

Profitability

Metric MNKD VOR Biotechnology median
Gross margin 75.39% 0.00% 65.16%
Operating margin 2.34% — 0.00%
Net margin (11.08%) 0.00% 0.00%
Free cash flow margin (4.61%) 0.00% 0.00%
Return on equity 71.36% (69.27%) (56.36%)
Return on assets (7.62%) 0.00% (48.04%)
Return on invested capital 2.36% 0.00% 0.00%

Growth

Metric MNKD VOR Biotechnology median
Revenue growth (TTM) 30.46% — 6.02%
EPS growth (last fiscal year) (80.00%) (107.35%) 30.26%
Revenue growth, 5-year CAGR 39.89% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNKD VOR Biotechnology median
Debt to equity (6.28) 0.21 0.00
Current ratio 1.72 10.69 4.72
Net debt to EBITDA 5.32 2.27 0.96

Dividend

Metric MNKD VOR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MNKD VOR Biotechnology median
Market cap 1.03b 1.14b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack